[1] MACDONALD R, BARNES K, HASTINGS C, et al. Mitochondrial abnormalities in Parkinson’s disease and Alzheimer’s disease: can mitochondria be targeted therapeutically? Biochem Soc Trans. 2018; 46(4):891-909.
[2] ABATE M, FESTA A, FALCO M, et al. Mitochondria as playmakers of apoptosis, autophagy and senescence. Semin Cell Dev Biol. 2020;98: 139-153.
[3] JOHNSON J, MERCADO-AYON E, MERCADO-AYON Y, et al. Mitochondrial dysfunction in the development and progression of neurodegenerative diseases. Arch Biochem Biophys. 2021;702:108698.
[4] ANNESLEY SJ, FISHER PR. Mitochondria in Health and Disease. Cells. 2019;8(7):680.
[5] WHITLEY BN, ENGELHART EA, HOPPINS S. Mitochondrial dynamics and their potential as a therapeutic target. Mitochondrion. 2019;49:269-283.
[6] YAPA NMB, LISNYAK V, RELJIC B, et al. Mitochondrial dynamics in health and disease. FEBS Lett. 2021;595(8):1184-1204.
[7] NG MYW, WAI T, SIMONSEN A. Quality control of the mitochondrion. Dev Cell. 2021;56(7):881-905.
[8] WU Y, CHEN M, JIANG J. Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling. Mitochondrion. 2019;49:35-45.
[9] NUNNARI J, SUOMALAINEN A. Mitochondria: in sickness and in health. Cell. 2012;148(6):1145-1159.
[10] IENCO EC, LOGERFO A, CARLESI C, et al. Oxidative stress treatment for clinical trials in neurodegenerative diseases. J Alzheimers Dis. 2011;24 Suppl 2:111-126.
[11] SEWERYN E, ZIAŁA A, GAMIAN A. Health-Promoting of Polysaccharides Extracted from Ganoderma lucidum. Nutrients. 2021;13(8):2725.
[12] 吴宜娟,莫明树,黄树宣.灵孢多糖对Aβ25-35损伤SH-SY5Y细胞保护作用的研究[J].热带医学杂志,2018,18(8):1006-1009.
[13] 于红梅,金永华.灵芝孢子粉对Guillain Barre综合征的疗效和作用机制[J].中风与神经疾病杂志,2013,30(12):1114-1115.
[14] ZENG P, GUO Z, ZENG X, et al. Chemical, biochemical, preclinical and clinical studies of Ganoderma lucidum polysaccharide as an approved drug for treating myopathy and other diseases in China. J Cell Mol Med. 2018;22(7):3278-3297.
[15] LI K, WANG Z. lncRNA NEAT1: Key player in neurodegenerative diseases. Ageing Res Rev. 2023;86:101878.
[16] ØVERGAARD KR, ØRBECK B. Children with neurodegenerative disease and obsessive-compulsive behaviour. Tidsskr Nor Laegeforen. 2020;140(6). doi: 10.4045/tidsskr.19.0703.
[17] LI R, ROBINSON M, DING X, et al. Genistein: A focus on several neurodegenerative diseases. J Food Biochem. 2022;46(7):e14155.
[18] YOUSEFI N, ABDOLLAHII S, KOUHBANANI MAJ, et al. Induced pluripotent stem cells (iPSCs) as game-changing tools in the treatment of neurodegenerative disease: Mirage or reality? J Cell Physiol. 2020; 235(12):9166-9184.
[19] HOU Y, DAN X, BABBAR M, et al. Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol. 2019;15(10):565-581.
[20] RAI SN, SINGH C, SINGH A, et al. Mitochondrial Dysfunction: a Potential Therapeutic Target to Treat Alzheimer’s Disease. Mol Neurobiol. 2020;57(7):3075-3088.
[21] VAN RENSBURG DJ, LINDEQUE Z, HARVEY BH, et al. Reviewing the mitochondrial dysfunction paradigm in rodent models as platforms for neuropsychiatric disease research. Mitochondrion. 2022;64:82-102.
[22] 冯鹏,胡珀,李慧,等.灵芝孢子粉在免疫调节中的作用及机制研究进展[J].药物生物技术,2021,28(3):308-314.
[23] CAI Q, LI Y, PEI G. Polysaccharides from Ganoderma lucidum attenuate microglia-mediated neuroinflammation and modulate microglial phagocytosis and behavioural response. J Neuroinflammation. 2017; 14(1):63.
[24] 杨海华,李毅,张丹桃,等.灵孢多糖对MPP+损伤PC12细胞的保护作用[J].中山大学学报(医学科学版),2007,28(4):393-396.
[25] GANGRAS P, GELFANOVA V, WILLIAMS GD, et al. Investigating SH-SY5Y Neuroblastoma Cell Surfaceome as a Model for Neuronal-Targeted Novel Therapeutic Modalities. Int J Mol Sci. 2022;23(23):15062.
[26] TAŞ CENGIZ Z, YILMAZ H, BEYHAN YE, et al. The Importance of Antioxidant Enzymes and Oxidative Stress in Human Fascioliasis. Turkiye Parazitol Derg. 2023;47(1):38-41.
[27] CHEN M, WU W, LIU D, et al. Evolution and Structure of API5 and Its Roles in Anti-Apoptosis. Protein Pept Lett. 2021;28(6):612-622.
[28] ASADI M, TAGHIZADEH S, KAVIANI E, et al. Caspase-3: Structure, function, and biotechnological aspects. Biotechnol Appl Biochem. 2022;69(4):1633-1645.
[29] YUAN Z, DEWSON G, CZABOTAR PE, et al. VDAC2 and the BCL-2 family of proteins. Biochem Soc Trans. 2021;49(6):2787-2795.
[30] CHAN DC. Mitochondrial Dynamics and Its Involvement in Disease. Annu Rev Pathol. 2020;15:235-259.
[31] GIACOMELLO M, PYAKUREL A, GLYTSOU C, et al. The cell biology of mitochondrial membrane dynamics. Nat Rev Mol Cell Biol. 2020; 21(4):204-224.
[32] RODRIGUES T, FERRAZ LS. Therapeutic potential of targeting mitochondrial dynamics in cancer. Biochem Pharmacol. 2020;182: 114282.
[33] ADEBAYO M, SINGH S, SINGH AP, et al. Mitochondrial fusion and fission: The fine-tune balance for cellular homeostasis. FASEB J. 2021; 35(6):e21620.
[34] KUMAR S, ASHRAF R, C K A. Mitochondrial dynamics regulators: implications for therapeutic intervention in cancer. Cell Biol Toxicol. 2022;38(3):377-406. |